The subcutaneous formulation developed using Halozyme's Enhanze drug delivery technology will therefore be indicated in Europe with J&J’s (NYSE:JNJ) cancer medicine Lazcluze as a first-line ...

As for its tolerability, based on 52 patients, J&J (NYSE:JNJ) said that TAR-200 indicated a safety profile consistent with prior findings, and there were no new safety signals. However ...

Biological targets represent a considerable test of our knowledge of the fundamental principles of molecular recognition. Effective modulation of biological events requires the generation of molecules ...

My laboratory is investigating translational regulation, RNA localization and RNA decay in spirochetes, including the organism that causes Lyme disease. I am particularly interested in the importance ...

Biochemistry & Molecular Genetics Home Faculty Edwards, Yvonne J.K., Ph.D. Faculty Edwards, Yvonne J.K., Ph.D. Dr. Edwards holds a Ph.D. and an M.S. in Bioinformatics ...

Partridge, S. M., and Westall, R. G., Biochem. J., 44, 418 (1949).